학술논문
Subcutaneous versus intravenous administration of bortezomib in patients with relapsed multiple myeloma: a randomised, phase 3, non-inferiority study
Document Type
Article
Author
Moreau, Philippe; Pylypenko, Halyna; Grosicki, Sebastian; Karamanesht, Ievgenii; Leleu, Xavier; Grishunina, Maria; Rekhtman, Grigoriy; Masliak, Zvenyslava; Robak, Tadeusz; Shubina, Anna; Arnulf, Bertrand; Kropff, Martin; Cavet, James; Esseltine, Dixie-Lee; Feng, Huaibao; Girgis, Suzette; van de Velde, Helgi; Deraedt, William; Harousseau, Jean-Luc
Source
In Lancet Oncology 2011 12(5):431-440
Subject
Language
ISSN
1470-2045